| CXSL0700020 | Y型PEG化重组人干扰素α2b注射液 | peginterferon alfa-2b | Injection | Biological Products(1) | New Drug Application | 2007-09-10 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2009-04-29 | view |
| CXSB1100008 | Y型PEG化重组人干扰素α2b注射液 | peginterferon alfa-2b | Injection | Biological Products | Supplementary Application | 2011-06-08 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2012-03-13 | view |
| CXSB1100015 | Y型PEG化重组人干扰素α2b注射液 | peginterferon alfa-2b | Injection | Biological Products | Supplementary Application | 2011-10-08 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2012-10-30 | view |
| CYSB2300129 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2023-07-12 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400241 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CXSS2300019 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(3.4) | New Drug Application | 2023-04-19 | | Changchun Lnstitute of Biological Products Co Ltd | | | view |
| CYSB2400242 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400240 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400243 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400238 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400239 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CXSL1100079 | 聚乙二醇化重组人干扰素α2b注射液 | | Injection | Biological Products(9) | New Drug Application | 2012-02-02 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2014-05-16 | view |
| CXSL1300097 | 聚乙二醇重组人干扰素α2b注射液 | | Injection | Biological Products(9) | New Drug Application | 2014-04-11 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2017-02-21 | view |
| CXSR1700002 | 聚乙二醇重组人干扰素α2b注射液 | | Injection | Biological Products | State Standards | 2017-05-03 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2017-09-05 | view |
| CXSL1300096 | 聚乙二醇重组人干扰素α2b注射液 | | Injection | Biological Products(9) | New Drug Application | 2014-04-11 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2017-02-21 | view |
| CXSR1700003 | 聚乙二醇重组人干扰素α2b注射液 | | Injection | Biological Products | State Standards | 2017-05-03 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2017-09-05 | view |
| CSS20020031 | 重组人α2b干扰素注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(4) | New Drug Application | 2002-07-10 | 长春生物制品研究所吉林省宝邑生物技术有限责任公司古巴海波尔生物技术公司 | | Certificate Issued | 2004-04-02 | view |
| CSS20020032 | 重组人α2b干扰素注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(4) | New Drug Application | 2002-07-10 | 长春生物制品研究所吉林省宝邑生物技术有限责任公司古巴海波尔生物技术公司 | | Certificate Issued | 2004-04-02 | view |
| J0300684 | 重组人干扰素α-2b 注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | License Renew | 2003-12-05 | 先灵葆雅（欧洲）公司 | Schering-Plough Europe | Approval Completed-Pending Certificated | 2004-03-23 | view |
| J0300683 | 重组人干扰素α-2b 注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | License Renew | 2003-12-05 | 先灵葆雅（欧洲）公司 | Schering-Plough Europe | Approval Completed-Pending Certificated | 2004-03-29 | view |
